PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.9600
-0.0100 (-1.03%)
Aug 28, 2025, 4:00 PM - Market closed
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$11,681,054
Market Cap
6.52M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 30, 2025 | 2 | 0 | - |
Apr 30, 2024 | 2 | 0 | - |
Apr 30, 2023 | 2 | -2 | -50.00% |
Apr 30, 2022 | 4 | 0 | - |
Apr 30, 2021 | 4 | 0 | - |
Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PMCB News
- 8 days ago - PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - Business Wire
- 10 days ago - PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Business Wire
- 1 year ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 1 year ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 1 year ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 1 year ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire
- 2 years ago - PharmaCyte Biotech Announces Final Results of Tender Offer - Business Wire
- 2 years ago - PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share - Business Wire